Shanghai Rightongene Biotechnology Co., Ltd. (SHA:688217)
China · Delayed Price · Currency is CNY 25.65
-0.03 (-0.12%)
Sep 30, 2026, 4:00 PM EDT
SHA:688217 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 137.65 | 104.96 | 139.15 | 161.95 | 204.22 | 123.76 |
Trading Asset Securities | 97.01 | 120.28 | 93.53 | 72.36 | 90.61 | 201.11 |
Cash & Short-Term Investments | 234.66 | 225.24 | 232.68 | 234.31 | 294.83 | 324.88 |
Cash Growth | 10.29% | -3.20% | -0.70% | -20.53% | -9.25% | 127.88% |
Accounts Receivable | 145.1 | 152.51 | 171.26 | 187.96 | 256.42 | 164.54 |
Other Receivables | 0.86 | 1.37 | 1.86 | 11.07 | 4.42 | 7.03 |
Receivables | 145.95 | 153.88 | 173.12 | 199.03 | 260.84 | 171.57 |
Inventory | 31.17 | 32.39 | 43.4 | 60.65 | 53.96 | 37.27 |
Other Current Assets | 17.38 | 16.28 | 20.93 | 15.9 | 14.86 | 22.58 |
Total Current Assets | 429.16 | 427.79 | 470.14 | 509.9 | 624.48 | 556.3 |
Property, Plant & Equipment | 331.98 | 345.34 | 366.12 | 365.34 | 276.01 | 212.77 |
Long-Term Investments | 65.41 | 43.14 | 47.92 | 47.76 | 56.76 | 56.76 |
Goodwill | - | 3.51 | 11.12 | 25.43 | 32.92 | 46.31 |
Other Intangible Assets | 24.66 | 27.85 | 41.06 | 49.61 | 40.04 | 46.35 |
Long-Term Deferred Tax Assets | 8.61 | 13.75 | 20.86 | 16.7 | 10.26 | 3.94 |
Long-Term Deferred Charges | 1.21 | 1.46 | 2.03 | 1.96 | 0.93 | 3.01 |
Other Long-Term Assets | 0.95 | 22.55 | 26.45 | 27.46 | 42.46 | 22.09 |
Total Assets | 861.97 | 885.39 | 985.7 | 1,044 | 1,084 | 947.53 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 6.3 | 12.68 | 11.27 | 14.37 | 51.18 | 11.18 |
Accrued Expenses | 10.55 | 10.88 | 14.2 | 17.62 | 21.42 | 13.4 |
Short-Term Debt | 1.51 | 1.51 | 1.51 | 1.51 | 2.86 | 0.88 |
Current Portion of Long-Term Debt | - | - | 2.52 | 2.52 | - | - |
Current Portion of Leases | 1.07 | 1.27 | 2.9 | 3.31 | 2.97 | 4.7 |
Current Income Taxes Payable | 1.13 | 1.45 | 2.18 | 0.11 | 7.41 | 0.26 |
Current Unearned Revenue | 0.99 | 0.95 | 2.12 | 2 | 2.84 | 1.7 |
Other Current Liabilities | 2.78 | 2.07 | 2.03 | 1.18 | 1.42 | 1.32 |
Total Current Liabilities | 24.32 | 30.81 | 38.72 | 42.61 | 90.09 | 33.44 |
Long-Term Debt | - | - | 13.75 | 16.25 | - | - |
Long-Term Leases | 0.66 | - | 1.75 | 5.75 | 8.1 | 3.96 |
Long-Term Unearned Revenue | 1.62 | 1.87 | 1.34 | 1.68 | 2.02 | 4.35 |
Long-Term Deferred Tax Liabilities | 2.91 | 3.41 | 4.91 | 6.81 | 8.16 | 5.52 |
Other Long-Term Liabilities | 3.9 | 3.09 | 4.59 | 3.39 | 4.08 | 3.6 |
Total Liabilities | 33.41 | 39.17 | 65.06 | 76.48 | 112.45 | 50.87 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 55.86 | 55.86 | 55.86 | 55.86 | 55.58 | 55.58 |
Additional Paid-In Capital | 732.16 | 732.16 | 732.16 | 735.89 | 725.16 | 717.56 |
Retained Earnings | 66.17 | 78.51 | 138.26 | 154.03 | 156.16 | 115.68 |
Treasury Stock | -17.03 | -17.03 | -17.03 | - | - | - |
Comprehensive Income & Other | -4.62 | -4.62 | - | - | - | - |
Total Common Equity | 832.53 | 844.88 | 909.26 | 945.78 | 936.9 | 888.81 |
Minority Interest | -3.97 | 1.35 | 11.39 | 21.9 | 34.53 | 7.85 |
Shareholders' Equity | 828.56 | 846.22 | 920.64 | 967.68 | 971.42 | 896.67 |
Total Liabilities & Equity | 861.97 | 885.39 | 985.7 | 1,044 | 1,084 | 947.53 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 3.24 | 2.78 | 22.42 | 29.33 | 13.92 | 9.53 |
Net Cash (Debt) | 231.43 | 222.46 | 210.26 | 204.98 | 280.91 | 315.35 |
Net Cash Growth | 10.93% | 5.80% | 2.58% | -27.03% | -10.92% | 121.80% |
Net Cash Per Share | 4.30 | 4.02 | 3.73 | 3.62 | 5.07 | 6.33 |
Filing Date Shares Outstanding | 55.19 | 55.19 | 55.19 | 55.86 | 55.58 | 55.58 |
Total Common Shares Outstanding | 55.19 | 55.19 | 55.19 | 55.86 | 55.58 | 55.58 |
Working Capital | 404.85 | 396.98 | 431.42 | 467.29 | 534.39 | 522.86 |
Book Value Per Share | 15.09 | 15.31 | 16.48 | 16.93 | 16.86 | 15.99 |
Tangible Book Value | 807.88 | 813.51 | 857.08 | 870.74 | 863.93 | 796.15 |
Tangible Book Value Per Share | 14.64 | 14.74 | 15.53 | 15.59 | 15.54 | 14.33 |
Buildings | 270.1 | 270.1 | 270.1 | 267.52 | 88.44 | 88.44 |
Machinery | 193.36 | 179.09 | 187.48 | 180.06 | 168.75 | 145.41 |
Construction In Progress | 60.85 | 79.73 | 69.94 | 43.24 | 115.68 | 58.61 |